A state-of-the-art technology developed by an expert from Hong Kong allows drug screening and discovery using a human heart-in-a-jar with genetic and immunologic make-up identical to the individual source.
A US FDA-approved ring oximeter developed by a start-up in Hong Kong enables screening of obstructive sleep apnoea (OSA) at home and can be used for treatment monitoring to enhance patients’ adherence.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.